Jessica Hopfield insider trades
Open-market stock purchases and sales by Jessica Hopfield, Director at Editas Medicine, Inc, from SEC Form 4 filings since Jul 27, 2015.
Track record: 20% of 5 scored buys are up 5% or more since purchase, averaging -9%.
Companies traded
- EDIT Editas Medicine, Inc: 3 buys, last Jun 17, 2026
- PODD Insulet Corp: 2 buys, 2 sales, last May 20, 2026
- MRVI Maravai Lifesciences Holdings, Inc: 1 buy, last Jun 16, 2025
- CELL Bruker Cellular Analysis, Inc: other filings, last Oct 2, 2023
- BLI Berkeley Lights, Inc: 1 buy, last May 26, 2022
- RDUS Radius Health, Inc: other filings, last Feb 20, 2020